Search - tctmd.com

Displaying 201 - 220 of 1391

Sort: Relevancy | Date

Presentation ESC 2018

2018 ESC/EACTS Guidelines on Myocardial Revascularization

Presenter: Franz-Josef Neumann

August 30, 2018

Presentation ESC 2018

Canadian Spontaneous Coronary Artery Dissection Cohort Study

Presenter: Jacqueline Saw

August 30, 2018

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation ESC 2018

FUnctional Testing Underlying REvascularization The FUTURE trial

Presenter: Gilles Rioufol

August 26, 2018

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

Presentation CHIP Seattle 2018

What to Do When the Artery Has No Flow?

Presenter: Perwaiz M. Meraj

August 10, 2018

Presentation

High-Sensitivity Troponins and Outcomes After MI

June 06, 2018

Presentation

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

May 21, 2018

Presentation

Four-Step Protocol for Disparities in STEMI Careand Outcomes in Women

May 07, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Basics of Coronary Physiology: From Coronary flow to Pressure Measurements (and everything in between)

Presenter: Javier Escaned

May 05, 2018

Presentation

Taking the Reins on Systems of Care for STEMI Patients - AHA Mission: Lifeline Program

May 01, 2018

Presentation SCAI 2018

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

Presenter: Andrew McNeice

April 28, 2018

Presentation TCTAP 2018

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Presenter: Duk-Woo Park

April 28, 2018

Presentation

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

April 23, 2018

Presentation

Mortality Following Nonemergent, Uncomplicated TLR After PCI

April 20, 2018

Presentation Fellows 2018

ACS Pharmacology for the Interventionalist

Presenter: Duane S. Pinto, Gregg W. Stone

April 13, 2018

Presentation

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

April 12, 2018

Presentation CIT 2018

Best of JACC: Cardiovascular Interventions 2017

Presenter: David J. Moliterno

March 23, 2018

Presentation ACC 2018

6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE)

Presenter: Hyeon-Cheol Gwon

March 12, 2018

Advertisement

2018 ESC/EACTS Guidelines on Myocardial Revascularization

Canadian Spontaneous Coronary Artery Dissection Cohort Study

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

FUnctional Testing Underlying REvascularization The FUTURE trial

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

What to Do When the Artery Has No Flow?

High-Sensitivity Troponins and Outcomes After MI

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

Four-Step Protocol for Disparities in STEMI Careand Outcomes in Women

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Basics of Coronary Physiology: From Coronary flow to Pressure Measurements (and everything in between)

Taking the Reins on Systems of Care for STEMI Patients - AHA Mission: Lifeline Program

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

Mortality Following Nonemergent, Uncomplicated TLR After PCI

ACS Pharmacology for the Interventionalist

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

Best of JACC: Cardiovascular Interventions 2017

6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content